Phathom Pharmaceuticals (PHAT) Depreciation and Depletion (2019 - 2023)
Phathom Pharmaceuticals (PHAT) reported Depreciation and Depletion of $100000.0 for Q3 2023, down 50.0% year-over-year from $200000.0 in Q3 2022, and little changed quarter-over-quarter from $100000.0 in Q2 2023.
Phathom Pharmaceuticals (PHAT) Depreciation and Depletion (2019 - 2023) Analysis & Trends
Phathom Pharmaceuticals (PHAT) has 5 years of Depreciation and Depletion data on file, last reported at $100000.0 in Q3 2023.
- Depreciation and Depletion for Q3 2023 came in at $100000.0, down 50.0% year-over-year; the trailing twelve-month figure through Sep 2023 was $400000.0 (down 22.18% YoY), and the FY2022 annual result was $600000.0, up 20.0% from the prior year.
- Depreciation and Depletion held at $100000.0 in Q3 2023 per PHAT's latest filing, from $100000.0 in the prior quarter.
- Over five years, Depreciation and Depletion peaked at $200000.0 in Q3 2022 and troughed at $2000.0 in Q3 2019.
- A 5-year average of $94588.2 and a median of $100000.0 in 2022 frame the typical range for Depreciation and Depletion.
- The sharpest annual moves came in 2020 and 2023: Depreciation and Depletion surged 4300.0% in 2020, then plunged 50.0% in 2023.
- A 5-year view of Depreciation and Depletion shows it stood at $6000.0 in 2019, then surged by 1283.33% to $83000.0 in 2020, then jumped by 37.35% to $114000.0 in 2021, then dropped by 12.28% to $100000.0 in 2022, then changed by 0.0% to $100000.0 in 2023.
- Business Quant data shows PHAT's Depreciation and Depletion at $100000.0 in Q3 2023, $100000.0 in Q2 2023, and $100000.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Phathom Pharmaceuticals | 895.99 Mn | 712.23 Mn | 46.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 100,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Mar 31, 2023 | 100,000.00 |
| Mar 31, 2023 | 100,000.00 |
| Dec 31, 2022 | 100,000.00 |
| Dec 31, 2022 | 100,000.00 |
| Sep 30, 2022 | 200,000.00 |
| Sep 30, 2022 | 200,000.00 |
| Jun 30, 2022 | 100,000.00 |
| Jun 30, 2022 | 100,000.00 |
| Mar 31, 2022 | 100,000.00 |
| Mar 31, 2022 | 100,000.00 |
| Dec 31, 2021 | 114,000.00 |
| Dec 31, 2021 | 114,000.00 |
| Sep 30, 2021 | 130,000.00 |
| Sep 30, 2021 | 130,000.00 |
| Jun 30, 2021 | 131,000.00 |
| Jun 30, 2021 | 131,000.00 |